United States
Premiumsupplier
LY2886721 CAS NO.1262036-50-9
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- N-(3-((4aS,7aS)-2-amino-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinamide
- LY2886721
Quick Details
- ProName: LY2886721
- CasNo: 1262036-50-9
- Molecular Formula: C18H16F2N4O2S
- Appearance: Solid powder
- Application: For research use only.
- Purity: 95%
- Storage: Store in a cool and dry place and at 0...
- LimitNum: 0
Superiority
We provide customized and high-quality LY2886721 product for your project.
Details
LY2886721, under the IUPAC name N-(3-(2-amino-4a,5,7,7a-tetrahydro-4H-furo(3,4-d)(1,3)thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinamide, is the first oral small molecule inhibitting Beta secretase (BACE) to reach Phase 2 clinical research. It was developed by Eli Lilly & Co. with the potention to treat Alzheimer's Disease.
